Skip to content
10-Q

Quarterly Report

EVOKE PHARMA, INC.

0001193125-25-278802

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 1.72M sh
Shares Diluted Q3 2025 · Sep 30, 2025 2.56M sh
Shares Diluted Q3 2025 · Sep 30, 2025 2.55M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.4M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.38M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$2.08M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$4.22M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $11.58M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $13.6M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3.36M
Stockholders Equity Q3 2025 · Jun 30, 2025 $4.37M
Stockholders Equity Q3 2025 · Mar 31, 2025 $5.84M
Stockholders Equity Q3 2025 · Dec 31, 2024 $7.04M
Stockholders Equity Q3 2025 · Sep 30, 2024 $4.39M
Stockholders Equity Q3 2025 · Jun 30, 2024 $2.66M
Stockholders Equity Q3 2025 · Mar 31, 2024 $3.5M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$2.58M
Current Liabilities Q3 2025 · Sep 30, 2025 $12.24M
Current Liabilities Q3 2025 · Dec 31, 2024 $10.38M
Total Liabilities Q3 2025 · Sep 30, 2025 $12.29M
Total Liabilities Q3 2025 · Dec 31, 2024 $10.48M
Current Assets Q3 2025 · Sep 30, 2025 $15.54M
Current Assets Q3 2025 · Dec 31, 2024 $17.24M
Total Assets Q3 2025 · Sep 30, 2025 $15.65M
Total Assets Q3 2025 · Dec 31, 2024 $17.52M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.45
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.58
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.94
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.01
Eps Basic Q3 2025 · Sep 30, 2025 −$0.45
Eps Basic Q3 2025 · Sep 30, 2025 −$1.58
Eps Basic Q3 2025 · Sep 30, 2024 −$0.94
Eps Basic Q3 2025 · Sep 30, 2024 −$3.01
Sga Expense Q3 2025 · Sep 30, 2025 $5.31M
Sga Expense Q3 2025 · Sep 30, 2025 $14.75M
Sga Expense Q3 2025 · Sep 30, 2024 $3.82M
Sga Expense Q3 2025 · Sep 30, 2024 $10.7M
Net Income Q3 2025 · Sep 30, 2025 −$1.16M
Net Income Q3 2025 · Sep 30, 2025 −$4.03M
Net Income Q3 2025 · Jun 30, 2025 −$1.57M
Net Income Q3 2025 · Mar 31, 2025 −$1.31M
Net Income Q3 2025 · Sep 30, 2024 −$1.31M
Net Income Q3 2025 · Sep 30, 2024 −$4.16M
Net Income Q3 2025 · Jun 30, 2024 −$1.27M
Net Income Q3 2025 · Mar 31, 2024 −$1.58M
Operating Income Q3 2025 · Sep 30, 2025 −$1.14M
Operating Income Q3 2025 · Sep 30, 2025 −$4M
Operating Income Q3 2025 · Sep 30, 2024 −$1.29M
Operating Income Q3 2025 · Sep 30, 2024 −$4.01M
Revenue Q3 2025 · Sep 30, 2025 $4.28M
Revenue Q3 2025 · Sep 30, 2025 $11.12M
Revenue Q3 2025 · Sep 30, 2024 $2.65M
Revenue Q3 2025 · Sep 30, 2024 $6.94M